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Abstract  
Background: Type 1 diabetes mellitus is an autoimmune disease caused by destruction of 
pancreatic islet beta cells and characterized by defect in insulin secretion. 
Objectives: The present study was carried out to investigate the hypoglycemic effects of Allium 
cepa in patients with type 1 diabetic patients.  
Results: In the assessment of the hypoglycaemic activity of Allium cepa in type 1 diabetic patients 
(n=21), crude Allium cepa (100g) caused a considerably lowered value in the fasting blood glucose 
levels by about 89 mg/dl in relation to insulin (145 mg/dl) after 4 hours. Also the ingestion of crude 
Allium cepa by type 1 diabetic patients produced a significant reduction in the induced 
hyperglycemia (GTT) by about 120 mg/dl in relation to water (77 mg/dl) and the standard drug 
insulin (153 mg/dl). 
Conclusion: Crude Allium cepa produced hypoglycemic effects, thus it could be used as a dietary 
supplement in management of diabetes. 
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ased on its etiology, diabetes mellitus 
is generally divided into three 
classifications: type 1, type 2 and 
gestational1. Type 1 is an autoimmune disease 
characterized by a defect in insulin secretion 
such that the pancreas produces little or no 
insulin. It occurs most often in children and 
young adults and accounts for 5-10% of cases 
of diabetes2. Type 2 diabetes is a metabolic 
disorder characterized by a defect in insulin 
secretion and/or the tissues are resistant to its 
uptake. Type 2 accounts for 90-95% of cases 
of diabetes1,2. The chronic hyperglycemia that 
characterizes diabetes mellitus results from 
defects in insulin secretion, insulin action, or 
both1. When left unchecked hyperglycemia 
can result in micro-macrovascular 
complications including: cardiovascular 
disease, nephropathy, neuropathy, and 
retinopathy2.  
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Insulin and oral hypoglycemic agents are used 
in the management of type 1 and type 2 
diabetes mellitus respectively1. 
Medicinal plants continue to provide valuable 
therapeutic agents, in both modern medicine 
and traditional systems3. Allium species such 
as onion has attracted particular attention of 
modern medicine because of its widespread 
health use around the world, and the 
cherished belief that it helps in maintaining 
good health, warding off illnesses and 
providing vigor4. Onion is rich in flavonoids 
such as quercetin and sulphur compounds, 
such as allyl propyl disulphide that have 
perceived benefits to human health5. These 
compounds possess antidiabetic, antibiotic, 
hypocholesterolaemic, fibrinolytic, and other 
various beneficial biological effects6.    
Materials and Methods  
Ethical approval  
The ethical approval for this study was 
obtained from the Ethical Committee/ 
University of Gezira/ Gezira State, Ministry 
of Health, Wad Medani-Sudan. Consent 
forms were signed by participants, being 
interested in joining the study completely 
voluntary. 
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Fresh and recently cropped Allium cepa 
harvested at the optimal maturity was 
purchased from the local market in Wad 
Medani city, Central Sudan. The fresh onion 
was cut into small slices to be taken orally by 
type 1 diabetic patients. 
Criteria for selecting patients 
For patients with type 1 diabetes mellitus, the 
following criteria of selection were 
considered: age ≤ 50 years, the duration of 
diabetes was between 2-5 years. Patients who 
are taking medicines for other health 
condition, taking vitamins or other 
supplements, smoking or consuming alcohol 
and those suffering from any of diabetes 
complications were excluded from the study. 
Type 1 diabetic patients 
Two groups of diabetic patients were used in 
this clinical trial to assess the hypoglycaemic 
effects of Allium cepa in type 1 diabetic 
patients. Participants of the first group (n=21)  
 
of both sexes were subjected to fasting blood 
glucose levels determination and subdivided 
into three subgroups each consisted of 7 
registered patients. Subgroup I participants 
were considered as negative control and 
received drinking water, while those in 
subgroup II were administered standard 
positive control treatment of regular insulin (5 
IU/prescribed doses). Subgroup III received 
100g of the crude fresh slices of Allium cepa 
as a test or investigational group.  
Determination of fasting blood glucose 
levels in type 1 diabetic patients 
 As designed for subgroup I, II and III and 
after the oral administration of water or 
regular insulin (5 IU/prescribed dose) and/or 
ingestion of the crude fresh Allium cepa slices 
(100g), fasting blood glucose levels were 
determined at 0, 1, 2 and 4 hours using 
electronic glucometer after the administration 
of the tested materials. (Table 1). 
 
Table 1: Fasting blood glucose levels in type 1 diabetic patients receiving water (5ml), insulin (5 




                        Blood glucose level (mg/dL, mean±S.E.M) Preparations 
4 h 2 h 1 h 0 h 
0.03 211±11.85 236±8.39 254.33±7.68 266±7.22 Water 
0.001 98.67±2.90 165±4.583 204±8.72 243± 8.08 Insulin 
0.005 143.38± 14.182 198.25±14.64 241±10.045 232±7.72 Allium cepa 
 
 
Figure 1: Fasting blood glucose levels in type 1 diabetic patients receiving water (5ml), insulin (5 
IU/prescribed dose) and Allium cepa (100g) 
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Determination of glucose tolerance tests in 
type 1 diabetic patients 
Another group of 21 type I diabetic patients, 
were subjected to glucose tolerance tests. 
They received 75 grams of dextrose dissolved 
in water orally. As designed in all subgroups, 
and after administration of water (subgroup I) 
or regular insulin (subgroup II) and/or 
ingestion of fresh slices of 100g Allium cepa 
(subgroup III), blood glucose levels were 
determined at 0, 1, 2 and 4 hours using 
electronic glucometer after the administration 
of the tested materials. (Table 2). 
Statistical Analysis 
All the data were expressed as means ± 
standard error of means (SEM) and analyzed 
by analysis of variance (ANOVA). 
Comparisons with the control group were 
made using One-way ANOVA. Differences 
were considered significant if P < 0.05.
 
Table 2: Glucose tolerance tests in type 1 diabetic patients receiving water (5ml), insulin 




                 Blood glucose level (mg/dL, mean±S.E.M) Preparations 
4 h 2 h 1 h 0 h 
0.03 328±14.33 368.5±15.11 405±16.34 259±17.12 Water 
0.001 152.67±15.69 208±24.269 304.33±16.19 205± 21.37 Insulin 







Figure 2: Glucose tolerance test curves in type 1 diabetic patients receiving water (5ml), insulin 
(prescribed doses) and Allium cepa (100g)  
 
Results and Discussion 
Fasting blood glucose levels in type 1 
diabetic patients 
Results obtained are shown in Table 1 and 
Figure 1. The blood glucose values in the 
subgroup I (negative control group) did not 
show much variations and the slight reduction 
in the blood glucose levels could be attributed 
to fasting. After the administration of insulin 
(prescribed dose) a significant reduction in 
the fasting blood glucose levels in subgroup II 
diabetic patients (positive control group) by 
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145 mg/dl was observed 4 hours later. While 
the administration of Allium cepa (100g) 
caused a considerably lowered value in the 
fasting blood glucose levels in subgroup III of 
diabetic patients (test group) by about 89 
mg/dl after 4 hours compared to reduction 
seen in subgroup I. Such effect was also 
evidently noted in a previous clinical study 
where the juice of Allium cepa (50 mg) was 
administered orally to diabetic patients 
despite the low dose taken by them7.  
Allium cepa acts as a hypoglycemic agent by 
mechanisms rather than increasing insulin 
levels. Allium cepa may have extra pancreatic 
effects, by acting directly on tissues, liver, 
muscles etc. and alter favourably the activities 
of the regulatory enzymes of glycolysis, 
gluconeogenesis and other pathways8-10. 
Glucose tolerance tests in type 1 diabetic 
patients 
Blood glucose levels for the three subgroups 
I, II, and III were determined at 0, 1, 2, and 4 
hours using glucometer. Results obtained 
showed that the administration of 75grams 
dextrose caused high increase in the blood 
glucose levels in the three subgroups after the 
first hour (hyperglycaemic peak).  It has been 
also observed that the administration of 
Allium cepa produced a significant reduction 
in the induced hyperglycemia by about 120 
mg/dl in relation to water (77 mg/dl) and the 
standard drug insulin (152 mg/dl) four hours 
later. While for the same period of time the 
effect of the oral administration of Allium 
cepa demonstrated a relatively slight and 
gradual decrease in fasting blood glucose 
levels by 13 mg/dl when compared to insulin 
(53 mg/dl) as shown in Table 2 and Figure 2.     
Similarly a clinical study performed by 
others, described such a decrease in glucose-
induced hyperglycemia in human adults8. 
The observed increase in fasting blood 
glucose levels during the first hour and after 
ingestion of Allium cepa is attributed to the 
glucogenic effects of cysteine present in 
Allium cepa11, a result that can counteract the 
common side effect of oral hypoglycemic 
agents currently used if Allium cepa is taken 
concurrently as food supplement. 
The number of study group is very small to 
reach concrete conclusions. Nevertheless, it 
was evident that, Allium cepa has 
hypoglycemic effects that may be beneficial 
in management of diabetes in addition to its 
other values. Other large scale double blinded 
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